Biomea Fusion Inc

Company Profile

Biomea Fusion Inc had its IPO on 2021-04-16 under the ticker symbol BMEA.

The company operates in the Healthcare sector and Biotechnology industry. Biomea Fusion Inc has a staff strength of 86 employees.

Stock update

Shares of Biomea Fusion Inc opened at $16.1 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $14.56 - $16.25, and closed at $14.71.

This is a -9.09% slip from the previous day's closing price.

A total volume of 495,649 shares were traded at the close of the day’s session.

In the last one week, shares of Biomea Fusion Inc have slipped by -14.13%.

Biomea Fusion Inc's Key Ratios

Biomea Fusion Inc has a market cap of $1.33 billion, indicating a price to book ratio of 1.4289 and a price to sales ratio of 0.

In the last 12-months Biomea Fusion Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-96447000. The EBITDA ratio measures Biomea Fusion Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biomea Fusion Inc’s operating margin was 0% while its return on assets stood at -42.29% with a return of equity of -76.25%.

In Q1, Biomea Fusion Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Biomea Fusion Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-3.4 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biomea Fusion Inc’s profitability.

Biomea Fusion Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.7789. Its price to sales ratio in the trailing 12-months stood at 0.

Biomea Fusion Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$112.64 million

Total Liabilities

$18.77 million

Operating Cash Flow

$-1756000.00

Capital Expenditure

$2.91 million

Dividend Payout Ratio

0%

Biomea Fusion Inc ended 2024 with $112.64 million in total assets and $0 in total liabilities. Its intangible assets were valued at $112.64 million while shareholder equity stood at $83.13 million.

Biomea Fusion Inc ended 2024 with $0 in deferred long-term liabilities, $18.77 million in other current liabilities, 3000.00 in common stock, $-160621000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $86.65 million and cash and short-term investments were $86.65 million. The company’s total short-term debt was $2,611,000 while long-term debt stood at $0.

Biomea Fusion Inc’s total current assets stands at $88.93 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $5.33 million and inventory worth $0.

In 2024, Biomea Fusion Inc's operating cash flow was $-1756000.00 while its capital expenditure stood at $2.91 million.

Comparatively, Biomea Fusion Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$14.71

52-Week High

$39.17

52-Week Low

$6.04

Analyst Target Price

$42.14

Biomea Fusion Inc stock is currently trading at $14.71 per share. It touched a 52-week high of $39.17 and a 52-week low of $39.17. Analysts tracking the stock have a 12-month average target price of $42.14.

Its 50-day moving average was $19 and 200-day moving average was $19.27 The short ratio stood at 10.03 indicating a short percent outstanding of 0%.

Around 2742.8% of the company’s stock are held by insiders while 4380.2% are held by institutions.